Universal Health Services Inc has a consensus price target of $177.72 based on the ratings of 27 analysts. The high is $256 issued by Barclays on July 26, 2024. The low is $90 issued by BMO Capital on July 6, 2022. The 3 most-recent analyst ratings were released by TD Cowen, Cantor Fitzgerald, and Barclays on July 26, 2024, respectively. With an average price target of $231.67 between TD Cowen, Cantor Fitzgerald, and Barclays, there's an implied 8.41% upside for Universal Health Services Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
07/26/2024 | Buy Now | 2.95% | TD Cowen | Gary Taylor | $183 → $220 | Maintains | Hold | Get Alert |
07/26/2024 | Buy Now | 2.48% | Cantor Fitzgerald | Sarah James | $162 → $219 | Upgrade | Underweight → Neutral | Get Alert |
07/26/2024 | Buy Now | 19.8% | Barclays | Andrew Mok | $198 → $256 | Upgrade | Equal-Weight → Overweight | Get Alert |
07/25/2024 | Buy Now | -6.41% | Stephens & Co. | Scott Fidel | $200 → $200 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
07/25/2024 | Buy Now | -24.19% | Cantor Fitzgerald | Sarah James | $162 → $162 | Reiterates | Underweight → Underweight | Get Alert |
07/10/2024 | Buy Now | -7.34% | Barclays | Andrew Mok | $189 → $198 | Maintains | Equal-Weight | Get Alert |
07/10/2024 | Buy Now | -24.19% | Cantor Fitzgerald | Sarah James | $162 → $162 | Reiterates | Underweight → Underweight | Get Alert |
07/09/2024 | Buy Now | -24.19% | Cantor Fitzgerald | Sarah James | $162 → $162 | Reiterates | Underweight → Underweight | Get Alert |
07/02/2024 | Buy Now | -24.19% | Cantor Fitzgerald | Sarah James | $162 → $162 | Reiterates | Underweight → Underweight | Get Alert |
06/26/2024 | Buy Now | 10.44% | Baird | Michael Ha | $198 → $236 | Upgrade | Neutral → Outperform | Get Alert |
05/30/2024 | Buy Now | -12.96% | JP Morgan | Lisa Gill | $182 → $186 | Maintains | Neutral | Get Alert |
05/30/2024 | Buy Now | -7.34% | Baird | Michael Ha | → $198 | Initiates | → Neutral | Get Alert |
05/20/2024 | Buy Now | 5.76% | UBS | A.J. Rice | $189 → $226 | Upgrade | Neutral → Buy | Get Alert |
05/07/2024 | Buy Now | -11.55% | RBC Capital | Ben Hendrix | $183 → $189 | Maintains | Sector Perform | Get Alert |
04/30/2024 | Buy Now | -14.36% | TD Cowen | Gary Taylor | $181 → $183 | Maintains | Hold | Get Alert |
04/26/2024 | Buy Now | -11.55% | Barclays | Andrew Mok | $181 → $189 | Maintains | Equal-Weight | Get Alert |
04/25/2024 | Buy Now | -13.43% | Stephens & Co. | Scott Fidel | → $185 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
04/12/2024 | Buy Now | -5% | Deutsche Bank | Pito Chickering | $208 → $203 | Maintains | Buy | Get Alert |
04/10/2024 | Buy Now | -27% | Cantor Fitzgerald | Sarah James | → $156 | Reiterates | Underweight → Underweight | Get Alert |
03/28/2024 | Buy Now | -6.41% | Wells Fargo | Stephen Baxter | $195 → $200 | Maintains | Overweight | Get Alert |
03/13/2024 | Buy Now | -14.83% | JP Morgan | Calvin Sternick | $144 → $182 | Maintains | Neutral | Get Alert |
03/12/2024 | Buy Now | -14.36% | RBC Capital | Ben Hendrix | $161 → $183 | Maintains | Sector Perform | Get Alert |
03/06/2024 | Buy Now | -6.41% | Mizuho | Ann Hynes | $175 → $200 | Maintains | Buy | Get Alert |
03/06/2024 | Buy Now | -15.3% | Barclays | Andrew Mok | → $181 | Initiates | → Equal-Weight | Get Alert |
03/05/2024 | Buy Now | -27% | Cantor Fitzgerald | Sarah James | → $156 | Reiterates | Underweight → Underweight | Get Alert |
03/04/2024 | Buy Now | -11.55% | Goldman Sachs | Jamie Perse | $170 → $189 | Maintains | Buy | Get Alert |
03/01/2024 | Buy Now | -15.3% | TD Cowen | Gary Taylor | $140 → $181 | Maintains | Market Perform | Get Alert |
02/29/2024 | Buy Now | -27% | Cantor Fitzgerald | Sarah James | $148 → $156 | Maintains | Underweight | Get Alert |
02/29/2024 | Buy Now | -9.68% | Citigroup | Jason Cassorla | $170 → $193 | Maintains | Buy | Get Alert |
02/29/2024 | Buy Now | -17.17% | UBS | Andrew Mok | $152 → $177 | Maintains | Neutral | Get Alert |
01/02/2024 | Buy Now | -17.17% | Wells Fargo | Stephen Baxter | → $177 | Upgrade | Equal-Weight → Overweight | Get Alert |
12/11/2023 | Buy Now | — | Goldman Sachs | Jamie Perse | — | Upgrade | Sell → Buy | Get Alert |
11/17/2023 | Buy Now | -32.61% | JP Morgan | Calvin Sternick | $152 → $144 | Maintains | Neutral | Get Alert |
10/20/2023 | Buy Now | -34.95% | Wells Fargo | Stephen Baxter | $153 → $139 | Maintains | Equal-Weight | Get Alert |
09/21/2023 | Buy Now | -33.55% | Barclays | Steven Valiquette | $142 → $142 | Maintains | Equal-Weight | Get Alert |
09/14/2023 | Buy Now | -30.74% | Cantor Fitzgerald | Sarah James | → $148 | Reiterates | Underweight → Underweight | Get Alert |
07/27/2023 | Buy Now | -14.36% | B of A Securities | Kevin Fischbeck | → $183 | Maintains | Buy | Get Alert |
07/27/2023 | Buy Now | -28.4% | Wells Fargo | Stephen Baxter | → $153 | Maintains | Equal-Weight | Get Alert |
07/27/2023 | Buy Now | -20.91% | Credit Suisse | Jonathan Yon | $163 → $169 | Maintains | Outperform | Get Alert |
07/26/2023 | Buy Now | -27.47% | Stephens & Co. | Scott Fidel | → $155 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
07/11/2023 | Buy Now | -20.45% | Mizuho | Ann Hynes | $150 → $170 | Maintains | Buy | Get Alert |
06/02/2023 | Buy Now | -23.72% | B of A Securities | Kevin Fischbeck | → $163 | Assumes | Neutral → Buy | Get Alert |
05/26/2023 | Buy Now | — | SVB Securities | Whit Mayo | — | Upgrade | Market Perform → Outperform | Get Alert |
05/16/2023 | Buy Now | -34.95% | Goldman Sachs | Jamie Perse | $124 → $139 | Maintains | Sell | Get Alert |
05/16/2023 | Buy Now | -29.8% | Mizuho | Ann Hynes | $140 → $150 | Maintains | Buy | Get Alert |
05/08/2023 | Buy Now | -27.93% | TD Cowen | Gary Taylor | $138 → $154 | Maintains | Market Perform | Get Alert |
04/27/2023 | Buy Now | -22.79% | Citigroup | Jason Cassorla | $150 → $165 | Maintains | Buy | Get Alert |
04/27/2023 | Buy Now | -32.14% | Stephens & Co. | Scott Fidel | $140 → $145 | Maintains | Equal-Weight | Get Alert |
04/27/2023 | Buy Now | -27.47% | Deutsche Bank | Pito Chickering | $145 → $155 | Maintains | Buy | Get Alert |
04/27/2023 | Buy Now | -28.87% | RBC Capital | Ben Hendrix | $130 → $152 | Maintains | Sector Perform | Get Alert |
04/27/2023 | Buy Now | -23.72% | Credit Suisse | Jonathan Yon | $153 → $163 | Maintains | Outperform | Get Alert |
04/25/2023 | Buy Now | -33.55% | Barclays | Steve Valiquette | $132 → $142 | Upgrade | Underweight → Equal-Weight | Get Alert |
04/21/2023 | Buy Now | -33.08% | Cantor Fitzgerald | Sarah James | → $143 | Initiates | → Underweight | Get Alert |
04/19/2023 | Buy Now | -27.47% | UBS | Andrew Mok | $167 → $155 | Maintains | Neutral | Get Alert |
04/19/2023 | Buy Now | -37.76% | JP Morgan | Calvin Sternick | → $133 | Initiates | → Neutral | Get Alert |
03/06/2023 | Buy Now | -32.14% | Deutsche Bank | Pito Chickering | $168 → $145 | Maintains | Buy | Get Alert |
03/06/2023 | Buy Now | -34.48% | Mizuho | Ann Hynes | $144 → $140 | Maintains | Buy | Get Alert |
03/06/2023 | Buy Now | -35.42% | Wells Fargo | Stephen Baxter | $154 → $138 | Maintains | Equal-Weight | Get Alert |
03/03/2023 | Buy Now | -28.4% | Credit Suisse | Jonathan Yon | $157 → $153 | Maintains | Outperform | Get Alert |
03/01/2023 | Buy Now | -39.16% | RBC Capital | Ben Hendrix | $114 → $130 | Maintains | Sector Perform | Get Alert |
03/01/2023 | Buy Now | -34.48% | Stephens & Co. | Scott Fidel | $155 → $140 | Maintains | Equal-Weight | Get Alert |
03/01/2023 | Buy Now | — | Wolfe Research | Justin Lake | — | Downgrade | Outperform → Peer Perform | Get Alert |
02/28/2023 | Buy Now | -25.13% | B of A Securities | Kevin Fischbeck | → $160 | Maintains | Neutral | Get Alert |
02/28/2023 | Buy Now | -27.47% | Stephens & Co. | Scott Fidel | → $155 | Reiterates | → Equal-Weight | Get Alert |
02/25/2023 | Buy Now | -25.13% | Deutsche Bank | Pito Chickering | $160 → $160 | Maintains | Buy | Get Alert |
01/24/2023 | Buy Now | -21.85% | UBS | Andrew Mok | $113 → $167 | Upgrade | Sell → Neutral | Get Alert |
01/09/2023 | Buy Now | -38.23% | Barclays | Steve Valiquette | $115 → $132 | Maintains | Underweight | Get Alert |
01/03/2023 | Buy Now | -27.93% | Wells Fargo | Stephen Baxter | → $154 | Upgrade | Underweight → Equal-Weight | Get Alert |
12/16/2022 | Buy Now | -32.14% | B of A Securities | Kevin Fischbeck | $120 → $145 | Upgrade | Underperform → Neutral | Get Alert |
12/14/2022 | Buy Now | -32.61% | Mizuho | Ann Hynes | $126 → $144 | Maintains | Buy | Get Alert |
11/25/2022 | Buy Now | -26.53% | Credit Suisse | Jonathan Yong | $129 → $157 | Maintains | Outperform | Get Alert |
11/14/2022 | Buy Now | -47.12% | UBS | Andrew Mok | $105 → $113 | Maintains | Sell | Get Alert |
11/02/2022 | Buy Now | -41.04% | Mizuho | Ann Hynes | $121 → $126 | Maintains | Buy | Get Alert |
11/01/2022 | Buy Now | -43.38% | Goldman Sachs | Jamie Perse | $110 → $121 | Maintains | Sell | Get Alert |
10/27/2022 | Buy Now | -46.65% | SVB Leerink | Whit Mayo | $98 → $114 | Maintains | Market Perform | Get Alert |
08/24/2022 | Buy Now | -46.18% | SVB Leerink | Whit Mayo | $111 → $115 | Maintains | Market Perform | Get Alert |
08/18/2022 | Buy Now | -48.99% | B of A Securities | Kevin Fischbeck | $106 → $109 | Maintains | Underperform | Get Alert |
07/29/2022 | Buy Now | -46.18% | Barclays | Steven Valiquette | $133 → $115 | Maintains | Underweight | Get Alert |
07/28/2022 | Buy Now | -48.06% | SVB Leerink | Whit Mayo | $103 → $111 | Maintains | Market Perform | Get Alert |
07/27/2022 | Buy Now | -34.02% | Citigroup | Jason Cassorla | $152 → $141 | Maintains | Buy | Get Alert |
07/27/2022 | Buy Now | -46.65% | RBC Capital | Frank Morgan | $130 → $114 | Maintains | Sector Perform | Get Alert |
07/26/2022 | Buy Now | -50.86% | UBS | Andrew Mok | $101 → $105 | Maintains | Sell | Get Alert |
07/15/2022 | Buy Now | -51.8% | SVB Leerink | Whit Mayo | $108 → $103 | Maintains | Market Perform | Get Alert |
07/13/2022 | Buy Now | -52.74% | UBS | Andrew Mok | $129 → $101 | Maintains | Sell | Get Alert |
07/12/2022 | Buy Now | -48.52% | Goldman Sachs | Jamie Perse | $125 → $110 | Maintains | Sell | Get Alert |
07/06/2022 | Buy Now | -57.88% | BMO Capital | Matt Borsch | → $90 | Downgrade | Market Perform → Underperform | Get Alert |
07/01/2022 | Buy Now | -50.4% | B of A Securities | Kevin Fischbeck | $123 → $106 | Maintains | Underperform | Get Alert |
07/01/2022 | Buy Now | -34.02% | Credit Suisse | A.J. Rice | $156 → $141 | Maintains | Outperform | Get Alert |
07/01/2022 | Buy Now | -43.38% | Mizuho | Ann Hynes | $153 → $121 | Maintains | Buy | Get Alert |
06/30/2022 | Buy Now | -49.46% | SVB Leerink | Whit Mayo | $132 → $108 | Maintains | Market Perform | Get Alert |
06/17/2022 | Buy Now | -46.18% | Loop Capital | Joseph France | → $115 | Initiates | → Hold | Get Alert |
05/13/2022 | Buy Now | -38.23% | SVB Leerink | Whit Mayo | $139 → $132 | Maintains | Market Perform | Get Alert |
05/03/2022 | Buy Now | -41.5% | Goldman Sachs | Jamie Perse | $144 → $125 | Maintains | Sell | Get Alert |
05/03/2022 | Buy Now | -28.4% | Mizuho | Ann Hynes | $164 → $153 | Maintains | Buy | Get Alert |
04/28/2022 | Buy Now | -44.78% | Wells Fargo | Stephen Baxter | $139 → $118 | Maintains | Underweight | Get Alert |
04/27/2022 | Buy Now | -37.76% | Barclays | Steven Valiquette | $145 → $133 | Maintains | Underweight | Get Alert |
04/27/2022 | Buy Now | -36.82% | Stephens & Co. | Scott Fidel | $150 → $135 | Maintains | Equal-Weight | Get Alert |
04/27/2022 | Buy Now | -26.06% | Credit Suisse | A.J. Rice | $172 → $158 | Maintains | Outperform | Get Alert |
04/27/2022 | Buy Now | -39.16% | RBC Capital | Ben Hendrix | $149 → $130 | Maintains | Sector Perform | Get Alert |
04/26/2022 | Buy Now | -39.63% | UBS | Andrew Mok | $134 → $129 | Maintains | Sell | Get Alert |
The latest price target for Universal Health Servs (NYSE:UHS) was reported by TD Cowen on July 26, 2024. The analyst firm set a price target for $220.00 expecting UHS to rise to within 12 months (a possible 2.95% upside). 36 analyst firms have reported ratings in the last year.
The latest analyst rating for Universal Health Servs (NYSE:UHS) was provided by TD Cowen, and Universal Health Servs maintained their hold rating.
The last upgrade for Universal Health Services Inc happened on July 26, 2024 when Cantor Fitzgerald raised their price target to $219. Cantor Fitzgerald previously had an underweight for Universal Health Services Inc.
The last downgrade for Universal Health Services Inc happened on March 1, 2023 when Wolfe Research changed their price target from N/A to N/A for Universal Health Services Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Universal Health Servs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Universal Health Servs was filed on July 26, 2024 so you should expect the next rating to be made available sometime around July 26, 2025.
While ratings are subjective and will change, the latest Universal Health Servs (UHS) rating was a maintained with a price target of $183.00 to $220.00. The current price Universal Health Servs (UHS) is trading at is $213.69, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.